• Sequana Medical receives certification under MDR, the new European Medical Device Regulation

    Monday February 14th 2022

  • New office and strengthened team for QbD Wallonia

    Friday February 11th 2022

  • Analyse van 2.658 tumoren werpt nieuw licht op mutaties in kanker

    Friday February 11th 2022

  • Medical device Morphemat® wins Gold ‘Business Innovation’ Henry van de Velde Award

    Wednesday February 9th 2022

  • Prime Minister Alexander De Croo opens Univercells’ new vaccine manufacturing site

    Tuesday February 8th 2022

  • Biocartis and Ophiomics to collaborate on liver cancer test

    Tuesday February 8th 2022

  • New strategic partner: BioLizard

    Tuesday February 8th 2022

  • Mithra obtains equity funding for up to EUR 100 million

    Monday February 7th 2022

  • Your news here?

  • UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results

    Friday February 4th 2022

  • eTheRNA announces research agreement with Merck to access mRNA technologies

    Thursday February 3rd 2022

  • VUB researchers discover how lactic acid weakens anti-tumour defences

    Monday January 31st 2022

Strategic Partners